- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ezra Launches 3T MRI/CT Combination for Full-Body Scans
The Ezra Blueprint scan reportedly includes quantitative brain measurements, coronary calcium scoring (CAC) and a full-body MRI that provides screening for over 500 conditions.
Offering a combination of 3T magnetic resonance imaging (MRI) and computed tomography (CT) that can provide fatty liver assessment, lung cancer screening and aneurysm detection with two hour-long appointments, Ezra has launched the Ezra Blueprint scan.
The Ezra Blueprint scan reportedly includes neurodegenerative assessment with brain MRI, artificial intelligence (AI)-powered quantification of subcutaneous fat and MRI angiography for possible diagnosis of brain aneurysm and carotid artery disease, according to Ezra, the developer of the Ezra Blueprint.
The newly launched Ezra Blueprint scan reportedly combines 3T MRI and CT for full-body scanning that facilitates screening for over 500 conditions. (Images courtesy of Ezra.)
Other features included in the Ezra Blueprint are high-resolution imaging of knee and hip joints, CT-based coronary calcium scoring (CAC) and full-body MRI that enables screening of over 500 conditions, according to Ezra.
After two 60-minute appointments to complete Ezra Blueprint scanning, Ezra said patients will subsequently receive a detailed radiology report and a consultation review by medical providers associated with Ezra.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
